CN102227213A - 适合于衍生化的胰岛素肽的口服施用的药物组合物 - Google Patents

适合于衍生化的胰岛素肽的口服施用的药物组合物 Download PDF

Info

Publication number
CN102227213A
CN102227213A CN2009801475240A CN200980147524A CN102227213A CN 102227213 A CN102227213 A CN 102227213A CN 2009801475240 A CN2009801475240 A CN 2009801475240A CN 200980147524 A CN200980147524 A CN 200980147524A CN 102227213 A CN102227213 A CN 102227213A
Authority
CN
China
Prior art keywords
insulin
pharmaceutical composition
composition according
derivatized
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801475240A
Other languages
English (en)
Chinese (zh)
Inventor
F.A.费格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/053017 external-priority patent/WO2009115469A1/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN102227213A publication Critical patent/CN102227213A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CN2009801475240A 2008-11-28 2009-09-18 适合于衍生化的胰岛素肽的口服施用的药物组合物 Pending CN102227213A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08170231.8 2008-11-28
EP08170231 2008-11-28
PCT/EP2009/053017 WO2009115469A1 (en) 2008-03-18 2009-03-13 Protease stabilized, acylated insulin analogues
EPPCT/EP2009/053017 2009-03-13
PCT/EP2009/062126 WO2010060667A1 (en) 2008-11-28 2009-09-18 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides

Publications (1)

Publication Number Publication Date
CN102227213A true CN102227213A (zh) 2011-10-26

Family

ID=40524842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801475240A Pending CN102227213A (zh) 2008-11-28 2009-09-18 适合于衍生化的胰岛素肽的口服施用的药物组合物

Country Status (5)

Country Link
US (1) US20110293714A1 (cg-RX-API-DMAC7.html)
EP (1) EP2370059A1 (cg-RX-API-DMAC7.html)
JP (1) JP2012510438A (cg-RX-API-DMAC7.html)
CN (1) CN102227213A (cg-RX-API-DMAC7.html)
WO (1) WO2010060667A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113631251A (zh) * 2019-03-15 2021-11-09 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2514406A1 (en) * 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
AU2008257505B2 (en) * 2007-06-01 2013-05-16 Novo Nordisk A/S Stable non-aqueous pharmaceutical compositions
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
BR112012016853A2 (pt) * 2010-01-12 2017-10-17 Novo Nordisk As "composições farmacêuticas para administração oral de peptídeos de insulina".
WO2012006956A1 (zh) 2010-07-14 2012-01-19 中国医学科学院药物研究所 一种胰岛素的脂质复合物及其制备方法和制剂
JP2013540771A (ja) 2010-10-15 2013-11-07 ノヴォ ノルディスク アー/エス 新規n末端修飾インスリン誘導体
CN103458873B (zh) * 2011-04-14 2016-04-13 诺沃—诺迪斯克有限公司 用于口服肽递送的脂肪酸酰化的氨基酸
WO2013093009A1 (en) 2011-12-21 2013-06-27 Novo Nordisk A/S N -terminally modified insulin derivatives
EA023447B1 (ru) * 2011-12-28 2016-06-30 Борис Славинович ФАРБЕР Производное инсулина, обладающее сахароснижающей активностью при пероральном применении, способ его получения и лекарственные формы на его основе
WO2013128003A1 (en) 2012-03-01 2013-09-06 Novo Nordisk A/S N-terminally modified oligopeptides and uses thereof
EP2836508B1 (en) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulin formulations
JP6285447B2 (ja) * 2012-10-17 2018-02-28 ノヴォ ノルディスク アー/エス 経口ペプチド送達用の脂肪酸アシル化d−アミノ酸
CN103405753B (zh) * 2013-08-13 2016-05-11 上海仁会生物制药股份有限公司 稳定的促胰岛素分泌肽水针药物组合物
US20160113906A1 (en) * 2014-09-19 2016-04-28 Board Of Regents, The University Of Texas System Methods of preparing extrudates
EP3215128B1 (en) 2014-11-04 2019-09-04 Innopharmax, Inc. Oral administration of unstable or poorly-absorbed drugs
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
EP3768094B1 (en) 2018-03-15 2024-05-01 R.P. Scherer Technologies, LLC Enteric softgel capsules
JP7778509B2 (ja) * 2021-09-24 2025-12-02 株式会社 資生堂 化粧料

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030050228A1 (en) * 2001-02-15 2003-03-13 Ekwuribe Nnochiri N. Methods of treating diabetes mellitus
WO2006035418A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Microcapsules comprising a methylxanthine and a corticosteroid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
EP2514406A1 (en) * 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
WO2009022006A1 (en) * 2007-08-15 2009-02-19 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030050228A1 (en) * 2001-02-15 2003-03-13 Ekwuribe Nnochiri N. Methods of treating diabetes mellitus
WO2006035418A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Microcapsules comprising a methylxanthine and a corticosteroid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113631251A (zh) * 2019-03-15 2021-11-09 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺
CN113631251B (zh) * 2019-03-15 2025-04-25 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺

Also Published As

Publication number Publication date
EP2370059A1 (en) 2011-10-05
US20110293714A1 (en) 2011-12-01
JP2012510438A (ja) 2012-05-10
WO2010060667A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
US20110293714A1 (en) Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
JP5908847B2 (ja) インスリンペプチドを経口投与するための医薬組成物
AU2009226910B2 (en) Protease stabilized, acylated insulin analogues
CN103458873B (zh) 用于口服肽递送的脂肪酸酰化的氨基酸
US20110144010A1 (en) Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
AU2013205275B2 (en) Protease stabilized, acylated insulin analogues

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111026

WD01 Invention patent application deemed withdrawn after publication